Dcf Advisers, LLC Bristol Myers Squibb CO Call Options Transaction History

Dcf Advisers, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $2.47 Million - $2.76 Million	42,600 New	42,600 $2.47 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $1.55 Million - $1.69 Million	25,000 New	25,000 $1.67 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.